Bey Douglas LLC Eli Lilly & CO Transaction History

Bey Douglas LLC

$132 Million
Q3 2025

A detailed history of Bey Douglas LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bey Douglas LLC holds 4,850 shares of LLY stock, worth $4.96 Million. This represents 2.79% of its overall portfolio holdings.

Number of Shares

4,850

Previous 6,317 23.22%

Holding current value

$4.96 Million

Previous $4.92 Million 24.86%

% of portfolio

2.79%

Previous 3.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$625.65 - $812.69 $917,828 - $1.19 Million	-1,467 Reduced 23.22%	4,850 $3.7 Million
Q2 2025 Jul 24, 2025	BUY	$713.71 - $898.95 $825,762 - $1.04 Million	1,157 Added 22.42%	6,317 $4.92 Million
Q1 2025 May 15, 2025	SELL	$725.72 - $929.72 $10,885 - $13,945	-15 Reduced 0.29%	5,160 $4.26 Million
Q4 2024 Jan 29, 2025	BUY	$727.2 - $932.06 $1.67 Million - $2.13 Million	2,290 Added 79.38%	5,175 $4 Million
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $2.23 Million - $2.77 Million	2,885 New	2,885 $2.56 Million

Others Institutions Holding LLY

# of Institutions

4,502

Shares Held

754M

Call Options Held

14.8M

Put Options Held

16.9M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $971B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bey Douglas LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bey Douglas LLC with notifications on news.

Account